INS and Insulin resistance: T2DM is categorized as a metabolic disease marked by two major physiological defects: resistance to insulin and beta cell malfunction, which do not arise simultaneously. Insulin resistance is described as a loss of sensitivity to insulin by target tissues, while beta cell dysfunction is described as inadequate insulin production by pancreatic beta cells to sustain normal glucose levels.